Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.8552 (-3.72%) ($6.8000 - $7.1971) on Tue. Sep. 24, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.18% (three month average) | RSI | 58 | Latest Price | $6.8552(-3.72%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -0.4% a day on average for past five trading days. | Weekly Trend | EYES advances 4.2% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) TAN(9%) IGOV(7%) UNG(7%) ICLN(5%) FIVG(4%) | Factors Impacting EYES price | EYES will decline at least -1.59% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) LQD(-6%) XOP(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.59% (StdDev 3.18%) | Hourly BBV | 0 () | Intraday Trend | -4.3% | | | |
|
5 Day Moving Average | $7.23(-5.18%) | 10 Day Moving Average | $7.06(-2.9%) | 20 Day Moving Average | $6.73(1.86%) | To recent high | -10.7% | To recent low | 17.4% | Market Cap | $2.19b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |